JPS6320550B2 - - Google Patents
Info
- Publication number
- JPS6320550B2 JPS6320550B2 JP55128928A JP12892880A JPS6320550B2 JP S6320550 B2 JPS6320550 B2 JP S6320550B2 JP 55128928 A JP55128928 A JP 55128928A JP 12892880 A JP12892880 A JP 12892880A JP S6320550 B2 JPS6320550 B2 JP S6320550B2
- Authority
- JP
- Japan
- Prior art keywords
- tube
- chamber
- infusion bag
- communication means
- hollow needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
【発明の詳細な説明】
<産業上の利用分野>
本発明は輸液バツグに関する。さらに詳しくは
ブドウ糖液とアミノ酸液とを分離して収容でき、
輸液に先立つて前記2つの輸液を簡便かつ無菌的
に混合することのできる輸液バツグに関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Field of Application> The present invention relates to an infusion bag. More specifically, glucose solution and amino acid solution can be stored separately.
The present invention relates to an infusion bag that allows the two infusion solutions to be mixed simply and aseptically prior to infusion.
<従来の技術>
近時、高カロリー輸液および人工腸管に関する
技術進歩が著しく、多数の患者の生命維持に広く
採用されるところとなつているが、患者に投与さ
れる輸液の変質を避けるために、ブドウ糖液、ア
ミノ酸液等の複数の輸液を別々に瓶中に保存し、
使用に先立つてそれぞれの瓶中の薬液を輸液セツ
ト等を使用して1つの瓶あるいはバツグ内に移送
して混合したり、また2つの瓶を両端に導液針を
有する連結管で液体連通して輸液を行つていた。<Conventional technology> In recent years, technological advances in high-calorie infusions and artificial intestinal tubes have been remarkable, and they are now being widely adopted for life support for many patients.However, in order to avoid deterioration of the infusions administered to patients, , multiple infusion solutions such as glucose solution and amino acid solution are stored separately in bottles,
Before use, the medicinal solution in each bottle is transferred and mixed into one bottle or bag using an infusion set or the like, or the two bottles are communicated with each other through a connecting tube with liquid guide needles at both ends. I was given an infusion.
<発明が解決しようとする問題点>
しかしながら前記の1つの瓶あるいはバツグ内
に移送して混合する方法は、混合前の輸液を収容
する複数の瓶、混合用の瓶あるいはバツグ、およ
び輸液セツト等の多数の容器や器具を必要とする
ばかりでなく、移送および混合操作を無菌的に実
施するための極度に慎重な取り扱いが要求され問
題であつた。<Problems to be Solved by the Invention> However, the above-mentioned method of transferring and mixing infusions into one bottle or bag requires a plurality of bottles containing infusions to be mixed, bottles or bags for mixing, infusion sets, etc. This problem not only requires a large number of containers and equipment, but also requires extremely careful handling in order to carry out the transfer and mixing operations aseptically.
また前記2つの瓶を液体連通して輸液を行う方
法は、特に、完全に混合しないと体内吸収が悪い
ブドウ糖液とアミノ酸液とを一緒に輸液する場合
には、両液は完全に混じることがなく、高張液で
あるブドウ糖液が先に輸液され、アミノ酸液の輸
液が後になるという欠点があり、従つて薬液の体
内吸収が悪く問題であつた。 In addition, the above-mentioned method of infusing the two bottles in fluid communication does not allow the two solutions to mix completely, especially when infusing glucose and amino acid solutions together, which are poorly absorbed in the body unless they are thoroughly mixed. However, there was a drawback that the glucose solution, which is a hypertonic solution, was injected first, and the amino acid solution was injected later, resulting in poor absorption of the medicinal solution into the body, which was a problem.
本発明は上記問題点に鑑みてなされたもので、
その目的とするところは、ブドウ糖液とアミノ酸
液とを分離して収容することができ、かつ両液の
無菌的な混合を簡便に行うことのできる経済的な
輸液バツグを提供することにある。 The present invention has been made in view of the above problems, and
The purpose is to provide an economical infusion bag that can separately contain a glucose solution and an amino acid solution and that can easily mix the two solutions in an aseptic manner.
<問題点を解決するための手段>
すなわち本発明は、アミノ酸液が収容される第
1の室とブドウ糖液が収容される第2の室とが液
密に画成されてなる可撓性バツグであつて、前記
第2の室の容積が収容されるブドウ糖液の量に加
え第1の室のアミノ酸液全量をも十分に収容でき
る大きさであり、かつ前記第1の室と第2の室の
仕切帯部に、該2つの室の連通を可能とする開封
可能な連通手段が設けられてなる輸液バツグであ
る。<Means for Solving the Problems> That is, the present invention provides a flexible bag in which a first chamber containing an amino acid solution and a second chamber containing a glucose solution are defined in a fluid-tight manner. The volume of the second chamber is large enough to accommodate the entire amount of the amino acid solution in the first chamber in addition to the amount of glucose solution accommodated, and the volume of the second chamber is large enough to accommodate the entire amount of the amino acid solution in the first chamber. This is an infusion bag in which an openable communication means that enables communication between the two chambers is provided on the partition band of the chamber.
<作用>
本発明の輸液バツグは、2つの室が液密に区画
形成されているので、1つのバツグでブドウ糖液
とアミノ酸液とを別々に分離して収容し保存する
ことができる。<Function> Since the infusion bag of the present invention has two chambers that are partitioned in a liquid-tight manner, a single bag can separately contain and store a glucose solution and an amino acid solution.
また第2の室の容積が収容されるブドウ糖液の
量に加え第1の室のアミノ酸液全量をも十分に収
容できる大きさなので、仕切帯部の連通手段を開
放すれば、外方からの圧迫等によりアミノ酸液を
ブドウ糖液の方に全量移行させることができ、従
つて第2の室を下にして外方から圧迫したり振盪
したりすることにより、容易にかつ無菌的に薬液
の混合を行うことができる。 In addition, the volume of the second chamber is large enough to accommodate not only the amount of glucose solution contained therein but also the entire amount of amino acid solution in the first chamber, so by opening the communication means of the partition band, it is possible to prevent leakage from the outside. The entire amount of the amino acid solution can be transferred to the glucose solution by pressure, etc. Therefore, by placing the second chamber facing down and applying pressure from the outside or shaking, the drug solution can be mixed easily and aseptically. It can be performed.
<実施例>
次に本発明の実施例について図面に基づいて説
明する。<Example> Next, an example of the present invention will be described based on the drawings.
第1図は本発明の一実施例にかかわる輸液バツ
グの正面図(薬液の導入口は省略してある)、第
2図ないし第6図はそれぞれ開封可能な連通手段
の例の拡大図である。 FIG. 1 is a front view of an infusion bag according to an embodiment of the present invention (the inlet for the drug solution is omitted), and FIGS. 2 to 6 are enlarged views of examples of communication means that can be opened. .
第1図に示すように本発明の輸液バツグ1は可
撓性シート、たとえば軟質の塩化ビニル製シート
で構成された輸液バツグであり、融着等の手段に
よつて2つの室4および5に仕切られ、仕切帯部
2にはこの2つの室4,5の連通を可能とする開
放可能な連通手段3が設けられている。そしてブ
ドウ糖液を収容する第2の室4の容積は収容され
るブドウ糖液の量より十分に大きく、第1の室5
に収容されるアミノ酸液を全量移行させてなおか
つ余裕のある大きさとなつている。 As shown in FIG. 1, an infusion bag 1 of the present invention is an infusion bag made of a flexible sheet, for example, a soft vinyl chloride sheet, and is divided into two chambers 4 and 5 by means such as fusing. The partition band 2 is provided with an openable communication means 3 that allows the two chambers 4 and 5 to communicate with each other. The volume of the second chamber 4 that accommodates the glucose solution is sufficiently larger than the amount of glucose solution that is accommodated, and the volume of the second chamber 4 that accommodates the glucose solution is sufficiently larger than that of the first chamber 5.
It is large enough to transfer the entire amount of amino acid solution stored in the container.
連通手段3は第2図に明瞭に示されるように、
隣接する2つの室4,5の仕切帯部2の一部を開
口して可撓性チユーブ部分6を構成し、このチユ
ーブ部分6にはステンレス鋼等の剛性ボール7
が、両室4,5内の液が混じらないように、密嵌
されてチユーブ部分6を閉塞している。 The communication means 3, as clearly shown in FIG.
Part of the partition strip 2 of the two adjacent chambers 4 and 5 is opened to form a flexible tube portion 6, and a rigid ball 7 made of stainless steel or the like is installed in the tube portion 6.
However, they are tightly fitted to close the tube portion 6 so that the liquids in both chambers 4 and 5 do not mix.
使用に際しては、まず第2の室4が下になるよ
うにして輸液バツグ1をハンガーなどに掛ける。
次に剛性ボール7を指でチユーブ部分6から離脱
させて2つの室4,5を連通せしめ、上方の第1
の室5から下方の第2の室に移行させる。そして
外方から手で圧迫したり振盪したりしてアミノ酸
液とブドウ糖液を混合し、出口ポート8から患者
への輸液の供給を行えばよい。 When in use, first hang the infusion bag 1 on a hanger or the like with the second chamber 4 facing down.
Next, the rigid ball 7 is detached from the tube part 6 with a finger to make the two chambers 4 and 5 communicate with each other, and the upper first
from chamber 5 to the second chamber below. Then, the amino acid solution and the glucose solution are mixed by manual pressure or shaking from the outside, and the infusion solution is supplied to the patient from the outlet port 8.
尚ビタミンや電解質液等の少量成分を添加する
必要がある場合には、第1図に示されるようなゴ
ム等の弾性体で作られた自己閉鎖性のプラグ9を
配置し、図示されていない注射針でこのプラグ9
を穿刺して注射筒内の液を輸液バツグ内に供給す
ればよい。 If it is necessary to add a small amount of ingredients such as vitamins or electrolyte solution, a self-closing plug 9 made of an elastic material such as rubber as shown in FIG. This plug 9 with a syringe needle
The liquid in the syringe can be supplied into the infusion bag by puncturing the syringe.
第3図は輸液バツグ1の輸送時等における剛性
ボール7のチユーブ部分6からの不時の離脱を防
止する手段を設けた連通手段であり、上下両室内
に若干延在した可撓性チユーブ10を仕切帯部2
に配置し、剛性ボール7によつてこのチユーブ1
0を閉塞した後、チユーブ10の上下延在部をヘ
アピン状等のクランプ11によつて閉止し上下室
間の連通を遮断した構造を採用している。使用に
際しては輸液バツグの外方からの操作でクランプ
11を開放し、剛性ボール7を離脱せしめて上下
の室を連通させればよい。 FIG. 3 shows a communication means provided with a means for preventing the rigid ball 7 from unintentionally detaching from the tube portion 6 during transport of the infusion bag 1, and includes a flexible tube 10 extending slightly into both the upper and lower chambers. Partition band part 2
This tube 1 is connected by a rigid ball 7.
After closing the tube 10, the vertically extending portion of the tube 10 is closed with a hairpin-shaped clamp 11, thereby blocking communication between the upper and lower chambers. In use, the clamp 11 may be opened by operating from the outside of the infusion bag, the rigid ball 7 may be removed, and the upper and lower chambers may be communicated with each other.
第4図の連通手段は、仕切帯部2の一部に設け
られた開口に一端封止の合成樹脂製の剛性チユー
ブ12を配置して、使用までの上下室間の連通を
遮断するものである。使用に際しては輸液バツグ
の外部から剛性チユーブ12の封止端部を保持し
てねじ切り開口させて上下空間を連通させるもの
であり、ねじ切りを容易にするために、この剛性
チユーブ12の一部に弱化部として狭小部13を
設けたり、この狭小部13の外周に切り込みを設
けておくのが好ましい。 The communication means shown in FIG. 4 has a rigid tube 12 made of synthetic resin sealed at one end placed in an opening provided in a part of the partition band 2 to block communication between the upper and lower chambers until use. be. When in use, the sealed end of the rigid tube 12 is held from the outside of the infusion bag and a threaded opening is made to communicate the upper and lower spaces.In order to facilitate thread cutting, a portion of the rigid tube 12 is weakened. It is preferable to provide a narrow part 13 as a part or to provide a cut on the outer periphery of this narrow part 13.
第5図の連通手段は、仕切帯部2の一部に設け
られたチユーブ状開口を合成樹脂のダイアフラム
15によつて密閉し、使用時に上下何れかの室に
封入された中空針17によつてダイアフラム15
を刺通して上下空間を連通させるものである。 The communication means shown in FIG. 5 seals a tube-shaped opening provided in a part of the partition band 2 with a synthetic resin diaphragm 15, and when in use, a hollow needle 17 sealed in either the upper or lower chamber. Tsute diaphragm 15
It is used to pierce through and connect the upper and lower spaces.
図示のごとく保持室16内に中空針17を収容
し、保持室16に中空針17の基端部を支持する
保持部を設けて中空針17を固定しておけば、輸
液バツグ輸送時等における中空針17の移動が防
止できるので、使用までのダイアフラム15ある
いは輸液バツグを構成するシートの中空針17に
よる刺通が防止される。 As shown in the figure, if the hollow needle 17 is housed in the holding chamber 16 and a holding part that supports the proximal end of the hollow needle 17 is provided in the holding chamber 16 to fix the hollow needle 17, it is possible to Since the hollow needle 17 can be prevented from moving, the hollow needle 17 is prevented from piercing the diaphragm 15 or the sheet constituting the infusion bag until use.
第6図の連通手段は、仕切帯部2開口からバツ
グ外に至るチユーブ18内に配置されたダイアフ
ラム19とこのダイアフラム19を刺通しうる無
空針20からなり、この無空針20の胴部がチユ
ーブ18内で摺動可能に密嵌支持されたものであ
る。連通操作は、バツグ外に位置する無空針20
の基端部を保持して無空針20を前進せしめダイ
アフラム19を破断した後、無空針20を後退せ
しめてチユーブ18のダイアフラム19より外方
に設けられた側孔21を開放させることにより行
う。この連通手段は輸液バツグを介することなく
直接無空針20の基端部を保持できるので連通操
作が確実となる。 The communication means shown in FIG. 6 consists of a diaphragm 19 disposed in a tube 18 extending from the opening of the partition band 2 to the outside of the bag, and a hollow needle 20 that can pierce the diaphragm 19. It is slidably and tightly fitted and supported within the tube 18. Communication operation is performed using the empty needle 20 located outside the bag.
By holding the proximal end of the tube 18 and advancing the empty needle 20 to break the diaphragm 19, the empty needle 20 is moved back to open the side hole 21 provided outside the diaphragm 19 of the tube 18. conduct. Since this communication means can directly hold the proximal end of the empty needle 20 without using an infusion bag, the communication operation becomes reliable.
また無空針20の不時の脱落あるいは無空針2
0とチユーブ18との間からの漏液を防止するた
めに、無空針20の基端部を可撓性の袋22によ
つて密封しておくこともできる。 Also, the empty needle 20 may accidentally fall off or the empty needle 2 may fall off accidentally.
In order to prevent liquid leakage between the empty needle 20 and the tube 18, the proximal end of the empty needle 20 can be sealed with a flexible bag 22.
<効果>
以上説明してきたことから明らかなように本発
明の輸液バツグは次のような利点を有する。<Effects> As is clear from the above explanation, the infusion bag of the present invention has the following advantages.
(1) 1つのバツグで、所望の混合比が得られるよ
うな量のアミノ酸液とブドウ糖液とを別々に分
離した形で収容し保存することができる。(1) A single bag can store and store separately an amino acid solution and a glucose solution in amounts that provide the desired mixing ratio.
(2) 第2の室が、混合するアミノ酸液とブドウ糖
液を十分に収容しうる大きさなので、両液の混
合が容易である。(2) Since the second chamber is large enough to sufficiently accommodate the amino acid solution and glucose solution to be mixed, mixing of both solutions is easy.
(3) アミノ酸液とブドウ糖液の混合を無菌的に行
うことができる。(3) Amino acid solution and glucose solution can be mixed aseptically.
第1図は本発明の一実施例にかかわる輸液バツ
グの正面図(薬液導入口は省略してある)、第2
図ないし第6図はそれぞれ開封可能な連通手段の
例の拡大図である。
<主な符号の説明>、1:輸液バツグ、2:仕
切帯部、3:連通手段、4:第2の室、5:第1
の室。
Figure 1 is a front view of an infusion bag according to an embodiment of the present invention (the drug solution inlet is omitted);
6 through 6 are enlarged views of examples of unsealable communication means, respectively. <Explanation of main symbols>, 1: Infusion bag, 2: Partition band, 3: Communication means, 4: Second chamber, 5: First
room.
Claims (1)
液が収容される第2の室とが液密に画成されてな
る可撓性バツグであつて、前記第2の室の容積が
収容されるブドウ糖液の量に加え第1の室のアミ
ノ酸液全量をも十分に収容できる大きさであり、
かつ前記第1の室と第2の室の仕切帯部に、該2
つの室の連通を可能とする開封可能な連通手段が
設けられてなる輸液バツグ。 2 前記連通手段が、可撓性チユーブと該チユー
ブを閉塞する剛性ボールとからなる特許請求の範
囲第1項記載の輸液バツグ。 3 前記連通手段が、一端が封止され該封止部を
開封するための破断可能な弱化部が設けられた剛
性チユーブである特許請求の範囲第1項記載の輸
液バツグ。 4 前記連通手段が、チユーブ状開口部と該チユ
ーブ状開口部を密閉するダイアフラムおよび該ダ
イアフラムを刺通しうる中空針とからなる特許請
求の範囲第1項記載の輸液バツグ。 5 前記中空針が可撓性バツグ内において中空針
の基端部を支持する保持部を具えた保持室内に収
容されていることを特徴とする特許請求の範囲第
4項記載の輸液バツグ。 6 前記連通手段が、第1の室からバツグ外に至
るチユーブと該チユーブ内に配置されたダイアフ
ラムと該ダイアフラムを刺通しうる無空針からな
り、該無空針の胴部が前記チユーブ内において摺
動可能に密嵌支持されており、該チユーブには第
2の室に連通する側孔が設けられ、無空針の基端
部がバツグの外に配置されていることを特徴とす
る特許請求の範囲第1項記載の輸液バツグ。 7 前記無空針の基端部が可撓性袋によつて密封
されている特許請求の範囲第6項記載の輸液バツ
グ。[Scope of Claims] 1. A flexible bag comprising a first chamber containing an amino acid solution and a second chamber containing a glucose solution, which are liquid-tightly defined, The volume of the chamber is large enough to accommodate not only the amount of glucose solution accommodated but also the entire amount of amino acid solution in the first chamber,
and on the partition band between the first chamber and the second chamber, said 2
An infusion bag provided with an openable communication means that enables communication between two chambers. 2. The infusion bag according to claim 1, wherein the communication means comprises a flexible tube and a rigid ball that closes the tube. 3. The infusion bag according to claim 1, wherein the communication means is a rigid tube sealed at one end and provided with a breakable weakened portion for opening the sealed portion. 4. The infusion bag according to claim 1, wherein the communication means comprises a tube-shaped opening, a diaphragm that seals the tube-shaped opening, and a hollow needle that can pierce the diaphragm. 5. The infusion bag according to claim 4, wherein the hollow needle is housed in a holding chamber provided with a holding part that supports the proximal end of the hollow needle within the flexible bag. 6. The communication means comprises a tube extending from the first chamber to the outside of the bag, a diaphragm disposed within the tube, and a hollow needle capable of piercing the diaphragm, and the body of the hollow needle slides inside the tube. A patent claim characterized in that the tube is movably supported in a tight fit, the tube is provided with a side hole communicating with the second chamber, and the proximal end of the empty needle is disposed outside the bag. The infusion bag according to item 1 of the scope of the invention. 7. The infusion bag according to claim 6, wherein the proximal end of the empty needle is sealed with a flexible bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55128928A JPS5752455A (en) | 1980-09-16 | 1980-09-16 | Bag for transfused liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55128928A JPS5752455A (en) | 1980-09-16 | 1980-09-16 | Bag for transfused liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5752455A JPS5752455A (en) | 1982-03-27 |
| JPS6320550B2 true JPS6320550B2 (en) | 1988-04-28 |
Family
ID=14996854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55128928A Granted JPS5752455A (en) | 1980-09-16 | 1980-09-16 | Bag for transfused liquid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5752455A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03129127A (en) * | 1988-03-26 | 1991-06-03 | Luk Lamellen & Kupplungsbau Gmbh | Automotive oscillation reduction device |
| WO2008096722A1 (en) | 2007-02-08 | 2008-08-14 | Otsuka Pharmaceutical Factory, Inc. | Agent for preventing bleeding from cerebral cortical vein |
| WO2012073891A1 (en) | 2010-11-29 | 2012-06-07 | 株式会社大塚製薬工場 | Transfusion preparation |
| WO2019176996A1 (en) | 2018-03-13 | 2019-09-19 | 株式会社大塚製薬工場 | Transfusion preparation |
| WO2022025231A1 (en) | 2020-07-31 | 2022-02-03 | 株式会社大塚製薬工場 | Nutrition formulation |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5975059A (en) * | 1982-10-22 | 1984-04-27 | テルモ株式会社 | Infusion liquid container |
| JPS59197257A (en) * | 1983-04-22 | 1984-11-08 | 藤山 悳正 | Nutritious solution transfusion bag |
| IT1214872B (en) * | 1984-04-06 | 1990-01-18 | Mariano Feriani | BAG CONTAINING TWO OR MORE SUBSTANCES FOR INFUSION FOR MEDICAL USE, PLACED IN SEPARATE COMPARTMENTS, INCLUDING MEANS SUITABLE TO ALLOW THE MIXING OF SUCH SUBSTANCES ONLY AT THE TIME OF USE. |
| JPS6429262A (en) * | 1987-07-27 | 1989-01-31 | Terumo Corp | Container for supplying medical liquid |
| AU639379B2 (en) * | 1990-11-07 | 1993-07-22 | Otsuka Pharmaceutical Factory, Inc. | Multi-chamber vessel |
| JP2630185B2 (en) * | 1991-10-25 | 1997-07-16 | 藤沢薬品工業株式会社 | Infusion device |
| JP3016348B2 (en) * | 1995-03-23 | 2000-03-06 | 株式会社ニッショー | Double chamber container |
| WO2008134828A2 (en) | 2007-05-04 | 2008-11-13 | Katholieke Universiteit Leuven | Tissue degeneration protection |
| US20140066439A1 (en) | 2010-11-10 | 2014-03-06 | Katholieke Universiteit Leuen, K.U.Leuven R&D | Osteoclast activity |
| CN104887503A (en) * | 2015-06-19 | 2015-09-09 | 安徽双鹤药用包装有限公司 | Soft infusion bag with dual-chamber structure and using method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH364073A (en) * | 1961-02-14 | 1962-08-31 | Vifor Sa | Mixing container |
| JPS565899Y2 (en) * | 1973-05-10 | 1981-02-09 | ||
| JPS50158388U (en) * | 1974-06-14 | 1975-12-27 | ||
| JPS5240621Y2 (en) * | 1974-07-31 | 1977-09-13 | ||
| JPS5528272Y2 (en) * | 1976-08-27 | 1980-07-05 | ||
| CH625416A5 (en) * | 1976-09-16 | 1981-09-30 | Solco Basel Ag | Flexible, transparent plastic container with connections for the withdrawal and transfusion of blood |
-
1980
- 1980-09-16 JP JP55128928A patent/JPS5752455A/en active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03129127A (en) * | 1988-03-26 | 1991-06-03 | Luk Lamellen & Kupplungsbau Gmbh | Automotive oscillation reduction device |
| WO2008096722A1 (en) | 2007-02-08 | 2008-08-14 | Otsuka Pharmaceutical Factory, Inc. | Agent for preventing bleeding from cerebral cortical vein |
| US8926548B2 (en) | 2007-02-08 | 2015-01-06 | Otsuka Pharmaceutical Factory, Inc. | Agent for preventing bleeding from cerebral cortical vein |
| WO2012073891A1 (en) | 2010-11-29 | 2012-06-07 | 株式会社大塚製薬工場 | Transfusion preparation |
| WO2019176996A1 (en) | 2018-03-13 | 2019-09-19 | 株式会社大塚製薬工場 | Transfusion preparation |
| WO2022025231A1 (en) | 2020-07-31 | 2022-02-03 | 株式会社大塚製薬工場 | Nutrition formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5752455A (en) | 1982-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0845969B1 (en) | Bag for containing a sterile medical solution | |
| US6039719A (en) | Bag for containing a sterile medical solution and method of mixing a sterile medical solution | |
| JPS6320550B2 (en) | ||
| US4829002A (en) | System for metering nutrient media to cell culture containers and method | |
| US3788369A (en) | Apparatus for transferring liquid between a container and a flexible bag | |
| US5257986A (en) | Container for the separate sterile storage of at least two substances and for mixing said substances | |
| EP0624358B1 (en) | Container with two compartments and mixing device | |
| JPS63317481A (en) | Vessel separating and storing active composition and mixing these composition | |
| EP0079326A2 (en) | Fluid transfer assembly | |
| JPH07505080A (en) | multi chamber container | |
| JP4236131B2 (en) | Medical container | |
| JPH08126683A (en) | Infusion container | |
| JPS63309263A (en) | Transfusion bag | |
| US5002530A (en) | Container for infusion solutions | |
| KR102920979B1 (en) | Sterile or sterilized package for administration of medicinal or nutritional substances | |
| TWI851131B (en) | Sterile flexible package with pressure compensator for the dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection | |
| GB2117733A (en) | Sterilized liquid mixing system | |
| JP4452903B2 (en) | Medical solution mixed solution bag | |
| NO322027B1 (en) | Bag for the storage and transport of sterile powdered products and for the manufacture of solutions of the products in the bag | |
| JPS6317474Y2 (en) | ||
| JPH05337163A (en) | Infusion container equipped with communication means | |
| CN223760111U (en) | A three-chamber infusion bag | |
| JP2000262589A (en) | Double chamber container | |
| JPH05123376A (en) | Container for infusion | |
| JPH0337623Y2 (en) |